Metformin

C-reactive protein ; Homo sapiens







63 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34676406 Metformin therapy is not associated with the lower prevalence of ascending aortic aneurysm in diabetic patients. 2022 Jan 24 1
2 35268272 Association of IL-10 and CRP with Pulse Wave Velocity in Patients with Abdominal Aortic Aneurysm. 2022 Feb 23 3
3 35351535 Effect of metformin as an add-on therapy on neuregulin-4 levels and vascular-related complications in adolescents with type 1 diabetes: A randomized controlled trial. 2022 Apr 1
4 35620570 Empagliflozin-Metformin Combination Has Antioxidative and Anti-Inflammatory Properties that Correlate with Vascular Protection in Adults with Type 1 Diabetes. 2022 1
5 33412927 Effect of Metformin on Circulating Levels of Inflammatory Markers in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. 2021 Sep 2
6 33718411 COVID-19 and Risk of Acute Ischemic Stroke and Acute Lung Injury in Patients With Type II Diabetes Mellitus: The Anti-inflammatory Role of Metformin. 2021 1
7 33798839 Effect of metformin on biomarkers of placental- mediated disease: A systematic review and meta-analysis. 2021 Apr 1
8 34630103 Efficacy and Safety of Metformin Use in Rheumatoid Arthritis: A Randomized Controlled Study. 2021 2
9 34717078 Effect of metformin on adiponectin in PCOS: A meta-analysis and a systematic review. 2021 Dec 2
10 31006835 The effect of metformin on biomarkers associated with breast cancer outcomes: a systematic review, meta-analysis, and dose-response of randomized clinical trials. 2020 Jan 1
11 32342619 Effect of metformin on cardiovascular risk factors in middle-aged Thai women with metabolic syndrome: A randomized placebo-controlled trial. 2020 Jul 1
12 32639009 Clinically relevant high levels of human C-reactive protein induces endothelial dysfunction and hypertension by inhibiting the AMPK-eNOS axis. 2020 Jul 17 1
13 32859615 Effect of Exercise or Metformin on Biomarkers of Inflammation in Breast and Colorectal Cancer: A Randomized Trial. 2020 Dec 1
14 30427060 Elevated circulating levels of monocyte activation markers among tuberculosis patients with diabetes co-morbidity. 2019 Mar 1
15 30890498 [Efficacy and safety of metformin for Behcet's disease and its effect on Treg/Th17 balance: a single-blinded, before-after study]. 2019 Feb 28 1
16 31326727 Liraglutide in combination with metformin may improve the atherogenic lipid profile and decrease C-reactive protein level in statin treated obese patients with coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial. 2019 Sep 1
17 31474368 Host-Microbe-Drug-Nutrient Screen Identifies Bacterial Effectors of Metformin Therapy. 2019 Sep 5 1
18 28081696 Effect of Metformin Therapy on Serum Fetuin Levels in Insulin Resistant Type 1 Diabetics. 2018 1
19 29168915 A Novel Microdevice for Rapid Neutrophil Purification and Phenotyping in Type 2 Diabetes Mellitus. 2018 Feb 1
20 29803716 Evidence-based nutritional and pharmacological interventions targeting chronic low-grade inflammation in middle-age and older adults: A systematic review and meta-analysis. 2018 Sep 1
21 29880175 The effects of different therapeutic modalities on cardiovascular risk factors in women with polycystıc ovary syndrome: A randomızed controlled study. 2018 Jun 1
22 28404960 Impact of metformin on C-reactive protein levels in women with polycystic ovary syndrome: a meta-analysis. 2017 May 23 8
23 28953677 Effects of metformin treatment on serum levels of C-reactive protein and interleukin-6 in women with polycystic ovary syndrome: a meta-analysis: A PRISMA-compliant article. 2017 Sep 6
24 25277876 Relationship of the Serum CRP Level With the Efficacy of Metformin in the Treatment of Type 2 Diabetes Mellitus: A Meta-Analysis. 2016 Jan 8
25 26950284 Effect of Metformin on Fibroblast Growth Factor-21 Levels in Patients with Newly Diagnosed Type 2 Diabetes. 2016 Mar 1
26 27018756 Adolescents with Classical Polycystic Ovary Syndrome Have Alterations in the Surrogate Markers of Cardiovascular Disease but Not in the Endothelial Function. The Possible Benefits of Metformin. 2016 Oct 1
27 25607338 The comparative effect of pioglitazone and metformin on serum osteoprotegerin, adiponectin and intercellular adhesion molecule concentrations in patients with newly diagnosed type 2 diabetes: a randomized clinical trial. 2015 May 1
28 25740979 Effect of metformin vs placebo on and metabolic factors in NCIC CTG MA.32. 2015 Mar 1
29 23981104 Long-term effects of metformin on endothelial function in type 2 diabetes: a randomized controlled trial. 2014 Jan 2
30 24622715 Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial. 2014 Feb 1
31 25555182 The benefit-to-risk ratio of common treatments in PCOS: effect of oral contraceptives versus metformin on atherogenic markers. 2014 Oct-Dec 2
32 22841520 The effect of metformin on monocyte secretory function in simvastatin-treated patients with impaired fasting glucose. 2013 Jan 1
33 23279603 Effect of metformin compared with hypocaloric diet on serum C-reactive protein level and insulin resistance in obese and overweight women with polycystic ovary syndrome. 2013 Apr 5
34 23359066 Effect of pioglitazone versus metformin on cardiovascular risk markers in type 2 diabetes. 2013 Feb 2
35 23378779 Antihyperglycemic, antihyperlipidemic, anti-inflammatory and adenosine deaminase- lowering effects of garlic in patients with type 2 diabetes mellitus with obesity. 2013 2
36 23674518 The lost correlation between leptin and CRP in type 2 diabetes. 2013 Mar 2
37 23988170 Evaluation of endocrine changes in women with the polycystic ovary syndrome during metformin treatment. 2013 Aug 1
38 24399727 Monocyte-suppressing effect of high-dose metformin in fenofibrate-treated patients with impaired glucose tolerance. 2013 1
39 22375259 Comparative Effects of Glibenclamide and Metformin on C-Reactive Protein and Oxidant/Antioxidant Status in Patients with Type II Diabetes Mellitus. 2012 Feb 2
40 22525206 Metformin-based treatment for obesity-related hypertension: a randomized, double-blind, placebo-controlled trial. 2012 Jul 1
41 22713099 Ethinylestradiol30μg-drospirenone and metformin: could this combination improve endothelial dysfunction in polycystic ovary syndrome? 2012 Jun 19 1
42 23107042 Lymphocyte-suppressing and systemic anti-inflammatory effects of high-dose metformin in simvastatin-treated patients with impaired fasting glucose. 2012 Dec 1
43 23677182 [Effect of metformin on the expression of tumor necrosis factor-α, Toll like receptors 2/4 and C reactive protein in obese type-2 diabetic patients]. 2012 Nov 1
44 21146883 Effect of metformin on oxidative stress, nitrosative stress and inflammatory biomarkers in type 2 diabetes patients. 2011 Jul 1
45 21865358 Effects of simvastatin and metformin on polycystic ovary syndrome after six months of treatment. 2011 Nov 1
46 19808911 Rosiglitazone decreases C-reactive protein to a greater extent relative to glyburide and metformin over 4 years despite greater weight gain: observations from a Diabetes Outcome Progression Trial (ADOPT). 2010 Jan 4
47 19937362 Comparison of the effects of sibutramine versus sibutramine plus metformin in obese women. 2010 Sep 1
48 19188739 Determinants of interleukin-6 and C-reactive protein vary in polycystic ovary syndrome, as do effects of short- and long-term metformin therapy. 2009 4
49 19488607 Short-term treatment with metformin improves the cardiovascular risk profile in first-degree relatives of subjects with type 2 diabetes mellitus who have a metabolic syndrome and normal glucose tolerance without changes in C-reactive protein or fibrinogen. 2009 May 1
50 17548076 C-reactive protein levels are unaffected by metformin during pretreatment and an IVF cycle in women with polycystic ovary syndrome. 2008 Mar 1